Ampio Pharmaceuticals exists for over 10 years now.
The science behind its leading drug is solid.
There were many trials - in none any safety concern rose.
Most promising indication is OAK and arthritis in general.
Phase-3 results are due to late September. In the last confernece management had clearly stated this timeline.
Other than that, the drug showed...